Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A gene detection kit and application for prognostic risk assessment of patients with liver cancer

A technology of genetic detection and risk assessment, applied in the determination/inspection of microorganisms, biochemical equipment and methods, DNA/RNA fragments, etc., to achieve the effect of small mutual interference, low degree and good amplification effect

Active Publication Date: 2021-08-03
MENGCHAO HEPATOBILIARY HOSPITAL OF FUJIAN MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, whether stable distinct prognostic subgroups do exist among HCC patients is unknown

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A gene detection kit and application for prognostic risk assessment of patients with liver cancer
  • A gene detection kit and application for prognostic risk assessment of patients with liver cancer
  • A gene detection kit and application for prognostic risk assessment of patients with liver cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0077] Method steps:

[0078] Randomly select 113 patients with liver cancer, according to the above-mentioned kit steps, first follow the Tranzol up Plus RNAKit experimental standard procedure to extract RNA in liver cancer tissue, and measure the concentration of the extracted RNA. Then take 1ug of RNA reverse transcription into cDNA, after the reverse transcription is completed, add 180ul of RNase-free water to dilute 10 times. Finally, real-time fluorescent quantitative PCR was used to detect the expression of each gene in the model in patient tissues.

[0079] The specific method is as follows:

[0080] (a) Patient tissue samples were obtained from preoperative biopsy, intraoperative or postoperative samples of liver cancer patients.

[0081] (b) Take soybean-sized fresh tissue blocks or tissue blocks frozen in liquid nitrogen to avoid blood clots.

[0082] (c) Add 2-3 pieces of DEPC water-soaked and air-dried magnetic beads and 1ml of TRIZOL reagent, place in a pre-co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a gene detection kit for liver cancer grouping and prognosis risk assessment, a mathematical model and its application in liver cancer grouping and prognosis risk assessment. Based on the next-generation sequencing technology and the TCGA (The Cancer Genome Atlas, Tumor Genome Atlas) database, the present invention establishes a liver cancer grouping and liver cancer prognosis risk assessment model. gene group. The present invention found a 6-gene model consisting of CA9, CXCL5, G6PD, MMP12, MYBL2 and SLC1A5, defined as the prognostic index PI=exp(p') / exp(1+p'), where p'=zCA9*1.64+ zCXCL5*1.22+zMMP12*1.52+1.93*zMYBL2+0.76*zSLC1A5+2.43*zG6PD‑3.86, this model can distinguish and judge different liver cancer prognosis subgroups, reflecting the prognosis risk of liver cancer patients.

Description

[0001] (1) Technical field [0002] The invention relates to a gene detection kit, a mathematical model and an application thereof for assessing the prognosis risk of patients with liver cancer. [0003] (2) Background technology [0004] The vast majority (70%-90%) of primary liver cancer (referred to as liver cancer) is hepatocellular carcinoma. Liver cancer is one of the most common causes of death from malignant tumors worldwide. The incidence of hepatocellular carcinoma (HCC) ranks sixth among malignant tumors worldwide and the second leading cause of cancer-related death. According to the global cancer statistics in 2012, the number of deaths due to hepatocellular carcinoma is 662,000 every year, and the number of liver cancer patients and deaths in China alone accounts for about 50% of the global liver cancer incidence and death. Although local treatments such as surgery and transcatheter arterial chemoembolization (TACE) can treat liver cancer and improve the survival ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886C12N15/11
CPCC12Q1/6886C12Q2600/118C12Q2600/158
Inventor 刘小龙刘景丰李振丽柯坤蔡志雄陈耕
Owner MENGCHAO HEPATOBILIARY HOSPITAL OF FUJIAN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com